BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 15018893)

  • 1. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
    Rak J; Yu JL
    Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.
    Rak J; Milsom C; May L; Klement P; Yu J
    Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy.
    Yu JL; May L; Klement P; Weitz JI; Rak J
    Semin Thromb Hemost; 2004 Feb; 30(1):21-30. PubMed ID: 15034795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
    Abdollahi A; Folkman J
    Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic therapy against gastrointestinal tract cancers.
    Iwasaki J; Nihira S
    Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
    Wachsberger P; Burd R; Dicker AP
    Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic cancer therapy.
    Cao Y
    Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
    Horsman MR; Bohn AB; Busk M
    Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy.
    Sato Y
    Cancer Sci; 2011 Jul; 102(7):1253-6. PubMed ID: 21401807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic strategies for cancer therapy (Review).
    Benouchan M; Colombo BM
    Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
    Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.